2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
47
Leukemia
28
Prostatic Neoplasms
21
Burkitt Lymphoma
17
Leukemia, Biphenotypic, Acute
15
Lymphoma
13
Leukemia, Myeloid, Acute
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Large B-Cell, Diffuse
6
Recurrence
5
Lymphoma, Non-Hodgkin
5
Myelodysplastic Syndromes
4
Hodgkin Disease
4
Pituitary Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Lymphoma, T-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, B-Cell
3
Dendritic Cell Sarcoma, Interdigitating
3
Breast Neoplasms
3
Anemia, Refractory, with Excess of Blasts
3
Rhabdoid Tumor
2
Polycystic Ovary Syndrome
2
Obesity
2
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Interventions
Deoxycholic Acid
3
Microbial Collagenase
2
ribociclib
1
Saline Solution
1
Radiofrequency Ablation
1
Isoproterenol
1
Hydrocortisone
1
Bandages
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lipoma
×
Hydrocortisone
×
Clear all
NCT04821583
2021-03-29
N-of-1 SLN
Erasmus Medical Center
Phase 3
Unknown
1 enrolled